Advanced Therapies Week brings the global advanced therapies community together for the most important week for doing business in advanced therapies. Home to the largest marketplace for tools and tech, Advanced Therapies Week is dedicated to helping biotech progress on their commercialisation journey, as well as pushing the industry one step closer to delivering life changing treatments to patients.
Advanced Therapies Week was created for knowledge sharing, relationship building and deal making; through the connections you create and the knowledge you share, you help advance the next pillar of medicine.
On the Agenda
ARMI’s Chief Technology Officer, Tom Bollenbach is chairing the Implementing New and Enabling Technologies into Existing Processes for Improved Commercial Outcomes session on Wednesday, January 26 at 1:30 pm.
ARMI’s Chief Regulatory Officer Dr. Richard McFarland is the session chair for the Achieving Best Practice in Quality Control and Assurance on Friday, January 28 at 11:00 am.
Technology of Tomorrow Zone
Get involved and exhibit in the Technology of Tomorrow Zone at the show. There are special rates available for ARMI BioFabUSA members – get in touch with David Green for more information,
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
